Aquavit appoints new chief medical technology officer
This article was originally published in Scrip
Executive Summary
Aquavit Pharmaceuticals, a company using desktop compounding technology for personalized medicine development, has appointed Dr David Shafer chief medical technology officer. Prior to joining New York, US-based Aquavit Dr Shafer launched the first Vectra XT 3D Imaging System, which allows patients view a 3D stimulation of a procedure on their body prior to surgery. He also created the first plastic surgery iPhone app. Dr Shafer will be responsible for R&D medical technology for Aquavit's product pipeline.